NN Investment Partners Holdings N.V. Buys 3,981 Shares of Hologic, Inc. (HOLX)

NN Investment Partners Holdings N.V. boosted its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 7.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 58,498 shares of the medical equipment provider’s stock after buying an additional 3,981 shares during the period. NN Investment Partners Holdings N.V.’s holdings in Hologic were worth $2,397,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Piedmont Investment Advisors LLC purchased a new stake in Hologic during the 2nd quarter valued at $127,000. Amussen Hunsaker Associates LLC purchased a new stake in Hologic during the 2nd quarter valued at $159,000. Lincoln Capital Corp purchased a new stake in Hologic during the 3rd quarter valued at $201,000. Homrich & Berg purchased a new stake in Hologic during the 2nd quarter valued at $204,000. Finally, Granite Springs Asset Management LLC purchased a new stake in Hologic during the 2nd quarter valued at $206,000. Institutional investors own 98.74% of the company’s stock.

In other news, insider Benjamin Jordan Cohn sold 3,437 shares of the stock in a transaction on Wednesday, September 19th. The stock was sold at an average price of $41.50, for a total transaction of $142,635.50. Following the transaction, the insider now owns 16,520 shares of the company’s stock, valued at approximately $685,580. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Christiana Stamoulis sold 30,967 shares of the stock in a transaction on Tuesday, October 2nd. The stock was sold at an average price of $40.70, for a total value of $1,260,356.90. Following the transaction, the director now directly owns 66,006 shares in the company, valued at approximately $2,686,444.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,661 shares of company stock worth $1,927,174. Insiders own 0.88% of the company’s stock.

HOLX stock opened at $39.99 on Tuesday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.99 and a current ratio of 1.29. Hologic, Inc. has a twelve month low of $35.10 and a twelve month high of $45.09. The firm has a market capitalization of $10.92 billion, a price-to-earnings ratio of 19.70, a price-to-earnings-growth ratio of 1.83 and a beta of 0.65.

Several research firms recently weighed in on HOLX. Needham & Company LLC increased their price target on Hologic from $43.00 to $48.00 and gave the company a “buy” rating in a report on Wednesday, August 1st. BidaskClub upgraded Hologic from a “hold” rating to a “buy” rating in a report on Wednesday, August 1st. BTIG Research restated a “buy” rating and set a $47.00 price target on shares of Hologic in a report on Thursday, August 2nd. Deutsche Bank increased their price target on Hologic from $42.00 to $45.00 and gave the company a “hold” rating in a report on Wednesday, August 1st. Finally, Canaccord Genuity decreased their price target on Hologic from $42.00 to $41.00 and set a “hold” rating on the stock in a report on Tuesday, August 14th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $44.47.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/11/06/nn-investment-partners-holdings-n-v-buys-3981-shares-of-hologic-inc-holx.html.

About Hologic

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Further Reading: Understanding Analyst Ratings

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply